Reporting of Clinical Trial Uncertainties With New Cancer Drugs in Journal Publications and Clinical Guidelines

Avi Cherla, Anita K. Wagner, Olivier J. Wouters, Steven Woloshin, Courtney Davis, Elias Mossialos, Huseyin Naci

Open source

DOI
10.1001/jama.2025.13917
Published
2025-10-28
Container
JAMA
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2025.13917,
  title = {Reporting of Clinical Trial Uncertainties With New Cancer Drugs in Journal Publications and Clinical Guidelines},
  author = {Avi Cherla and Anita K. Wagner and Olivier J. Wouters and Steven Woloshin and Courtney Davis and Elias Mossialos and Huseyin Naci},
  year = {2025},
  journal = {JAMA},
  doi = {10.1001/jama.2025.13917},
  url = {https://doi.org/10.1001/jama.2025.13917}
}

RIS

TY  - JOUR
TI  - Reporting of Clinical Trial Uncertainties With New Cancer Drugs in Journal Publications and Clinical Guidelines
AU  - Avi Cherla
AU  - Anita K. Wagner
AU  - Olivier J. Wouters
AU  - Steven Woloshin
AU  - Courtney Davis
AU  - Elias Mossialos
AU  - Huseyin Naci
PY  - 2025
JO  - JAMA
DO  - 10.1001/jama.2025.13917
UR  - https://doi.org/10.1001/jama.2025.13917
ER  - 

APA

Cherla, A., Wagner, A. K., Wouters, O. J., Woloshin, S., Davis, C., Mossialos, E., & Naci, H. (2025). Reporting of Clinical Trial Uncertainties With New Cancer Drugs in Journal Publications and Clinical Guidelines. JAMA. https://doi.org/10.1001/jama.2025.13917

Source records